Bevacizumab as Therapy for Radiation Necrosis in Four Children With Pontine Gliomas

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 4, 2009, Pages 1148-1154

  Liu, Arthur K ^a   Macy, Margaret E ^b   Foreman, Nicholas K ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

Bevacizumab; Diffuse pontine glioma; Pediatric; Radiation necrosis

Indexed keywords

BEVACIZUMAB; BRAIN TUMORS; CLINICAL OUTCOME; DIAGNOSTIC INFORMATION; DISEASE PROGRESSION; QUALITY OF LIFE; RADIATION NECROSIS; RADIATION THERAPY; SIDE EFFECT; STEROID THERAPY; THERAPEUTIC BENEFITS; UNIVERSITY OF COLORADO; VASCULAR ENDOTHELIAL GROWTH FACTOR;

DIAGNOSIS; PEDIATRICS; TUMORS;

RADIATION;

BEVACIZUMAB; DEXAMETHASONE; MANNITOL; DEXAMETHASONE 21-PHOSPHATE; DEXAMETHASONE SODIUM PHOSPHATE; DRUG DERIVATIVE; GLUCOCORTICOID; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ARTICLE; BRADYCARDIA; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CHILD; CHILDHOOD CANCER; CRANIAL NERVE PARALYSIS; DRUG DOSE REDUCTION; FACIAL NERVE PARALYSIS; FATIGUE; FEMALE; GENERAL CONDITION DETERIORATION; GLIOBLASTOMA; GLIOMA; HUMAN; LIMB WEAKNESS; MALE; MEDICAL RECORD REVIEW; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS GLIOMA; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION NECROSIS; RETROSPECTIVE STUDY; SLURRED SPEECH; SOMNOLENCE; STEROID THERAPY; TACHYCARDIA; TREATMENT OUTCOME; WEAKNESS; BRAIN; BRAIN TUMOR; DRUG ANTAGONISM; EVALUATION; FATALITY; NECROSIS; PATHOLOGY; PONS; QUALITY OF LIFE; RADIATION EXPOSURE; RADIATION INJURY; RADIOSURGERY;

ANTIBODIES, MONOCLONAL; BRAIN; BRAIN NEOPLASMS; CHILD; DEXAMETHASONE; FATAL OUTCOME; FEMALE; GLIOMA; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NECROSIS; PONS; QUALITY OF LIFE; RADIATION INJURIES; RADIOSURGERY; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70449702351     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.12.032     Document Type: Article

References (17)

1. Packer R.J., Boyett J.M., Zimmerman R.A., et al. Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group phase I/II trial. Cancer 72 (1993) 1414-1421
2. Freeman C.R., Krischer J.P., Sanford R.A., et al. Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: A Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 27 (1993) 197-206
3. Mandell L.R., Kadota R., Freeman C., et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43 (1999) 959-964
4. Korones D.N., Fisher P.G., Kretschmar C., et al. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: A Children's Oncology Group phase II study. Pediatr Blood Cancer 50 (2008) 227-230
5. Gonzalez J., Kumar A.J., Conrad C.A., et al. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67 (2007) 323-326
6. Wong E.T., Huberman M., Lu X.Q., et al. Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol 26 (2008) epub ahead of print
7. Nelson Jr. M.D., Soni D., and Baram T.Z. Necrosis in pontine gliomas: Radiation induced or natural history?. Radiology 191 (1994) 279-282
8. Packer R.J., Zimmerman R.A., Kaplan A., et al. Early cystic/necrotic changes after hyperfractionated radiation therapy in children with brain stem gliomas. Data from the Childrens Cancer Group. Cancer 71 (1993) 2666-2674
9. Bartholdi D., Rubin B.P., and Schwab M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat. Eur J Neurosci 9 (1997) 2549-2560
10. Tsao M.N., Li Y.Q., Lu G., et al. Upregulation of vascular endothelial growth factor is associated with radiation-induced blood-spinal cord barrier breakdown. J Neuropathol Exp Neurol 58 (1999) 1051-1060
11. Li Y.Q., Ballinger J.R., Nordal R.A., et al. Hypoxia in radiation-induced blood-spinal cord barrier breakdown. Cancer Res 61 (2001) 3348-3354
12. Nordal R.A., Nagy A., Pintilie M., et al. Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: A role for vascular endothelial growth factor. Clin Cancer Res 10 (2004) 3342-3353
13. Batchelor T.T., Sorensen A.G., di Tomaso E., et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11 (2007) 83-95
14. Bender J.L., Adamson P.C., Reid J.M., et al. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: A Children's Oncology Group Study. J Clin Oncol 26 (2008) 399-405
15. Benesch M., Windelberg M., Sauseng W., et al. Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors. Ann Oncol 19 (2008) 807-813
16. Kumar A.J., Leeds N.E., Fuller G.N., et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 217 (2000) 377-384
17. Mullins M.E., Barest G.D., Schaefer P.W., et al. Radiation necrosis versus glioma recurrence: Conventional MR imaging clues to diagnosis. AJNR Am J Neuroradiol 26 (2005) 1967-1972